ANGIODYNAMICS INC

By person

26 insiders · 68 transactions

15.8×

James C. Clemmer holds 15.8 times base salary in stock. $12.70M of shares against $803.03K in salary for 2025.

Salary from the company's own proxy. The shares are what James C. Clemmer last reported holding, valued at $14.72, the price Common Stock was last bought or sold at on the open market here, on 30 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Avista Capital Partners GP, LLC entity

10% owner

—

$70.39M (5)

−$70.39M

381,406

0.9228%

$5.61M

−92.7%

Burgstahler David F

Director

—

$70.39M (5)

−$70.39M

405,394

0.9808%

$5.97M

−92.3%

Clemmer James C

President and CEO

$1.61M (9)

—

+$1.61M

862,448

2.09%

$12.70M

+1,286%

Richard Stark

SVP, GM - Oncology

—

$446.49K (1) scheduled

−$446.49K

20,754

0.0502%

$305.50K

+12.6%

Helsel Dave

SVP Global Operations and R&D

—

$432.51K (5)

−$432.51K

28,289

0.0684%

$416.41K

+62.0%

Nighan Warren JR

SVP Quality and Regulatory

$5.29K (2)

$393.99K (2)

−$388.70K

64,745

0.1566%

$953.05K

+264.0%

Centea Scott

SVP/GM, VIT

—

$335.04K (1) scheduled

−$335.04K

58,128

0.1406%

$855.64K

+33.1%

JOHNSON WESLEY

Director

—

$293.28K (3)

−$293.28K

155,425

0.3760%

$2.29M

+299.8%

Gould Kevin J

Director

—

$292.79K (1) scheduled

−$292.79K

77,504

0.1875%

$1.14M

+141.5%

Campbell Chad Thomas

SVP/GM, Vascular Access

—

$291.81K (1) scheduled

−$291.81K

108,676

0.2629%

$1.60M

+527.2%

Weiss Lawrence T

SVP, Chief Legal Officer

$118.10K (1)

—

+$118.10K

91,330

0.2210%

$1.34M

—

DONNELLY HOWARD W

Director

$78.60K (1)

—

+$78.60K

178,938

0.4329%

$2.63M

+324.6%

Trowbridge Stephen A

EVP and CFO

$67.00K (5)

—

+$67.00K

305,796

0.7398%

$4.50M

+614.1%

Greiner Michael

EVP and CFO

—

$41.75K (1)

−$41.75K

33,438

0.0809%

$492.21K

+234.4%

REED JAN STERN

Director

$5.06K (1)

—

+$5.06K

116,921

0.2829%

$1.72M

—

Meteny Dennis S

Director

—

140,019

0.3388%

$2.06M

+132.6%

Auen Eileen O'Shea

Director

—

116,605

0.2821%

$1.72M

—

Licitra Karen A

Director

—

102,322

0.2476%

$1.51M

—

Tarnoff Michael E

Director

—

95,265

0.2305%

$1.40M

—

GOLD JEFFREY

Director

—

83,640

0.2024%

$1.23M

+60.7%

Piccinini Laura

SVP International

—

81,929

0.1982%

$1.21M

—

Burgess Lorinda

Director

—

67,144

0.1624%

$988.36K

—

LaPorte Steve

Director

—

48,484

0.1173%

$713.68K

+41.8%

ROSENZWEIG RICHARD C

SVP and General Counsel

—

15,730

0.0381%

$231.55K

—

Simpson Robert Arthur

SVP/GM, Global Vascular

—

15,441

0.0374%

$227.29K

—

Boucher Brent J.

SVP and GM of Oncology

—

15,416

0.0373%

$226.92K

+9.9%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Nighan Warren JR

30 Jul 2026

SVP Quality and Regulatory

Sell

23,370

$14.72

$344.01K

Weiss Lawrence T

21 Oct 2025

SVP, Chief Legal Officer

Buy

10,000

$11.81

$118.10K

Trowbridge Stephen A

13 Oct 2025

EVP and CFO

Buy

890

$11.16

$9.93K

Clemmer James C

9 Oct 2025

President and CEO

Buy

10,000

$11.15

$111.50K

Nighan Warren JR

16 Jan 2025

SVP Quality and Regulatory

Sell

4,060

$12.31

$49.98K

Nighan Warren JR

10 Oct 2024

SVP Quality and Regulatory

Buy

100

$6.08

$608.00

Trowbridge Stephen A

8 Oct 2024

EVP and CFO

Buy

1,700

$5.86

$9.96K

Clemmer James C

7 Oct 2024

President and CEO

Buy

20,000

$6.03

$120.60K

Nighan Warren JR

7 Oct 2024

SVP Quality and Regulatory

Buy

768

$6.09

$4.68K

Clemmer James C

8 Apr 2024

President and CEO

Buy

10,000

$6.70

$67.00K

Helsel Dave

31 Jan 2023

SVP Global Operations and R&D

Sell

4,633

$12.95

$60.00K

Trowbridge Stephen A

12 Oct 2022

EVP and CFO

Buy

1,083

$13.82

$14.97K

Clemmer James C

10 Oct 2022

President and CEO

Buy

10,000

$15.00

$150.00K

Helsel Dave

29 Jul 2022

SVP Global Operations and R&D

Sell

5,000

$22.44

$112.20K

Trowbridge Stephen A

15 Jul 2022

EVP and CFO

Exercised, kept

14,758

$15.95

$235.39K

JOHNSON WESLEY

15 Jul 2022

Director

Exercised, kept

6,022

$15.95

$96.05K

Meteny Dennis S

12 Jul 2022

Director

Exercised, kept

6,022

$15.95

$96.05K

Helsel Dave

28 Apr 2022

SVP Global Operations and R&D

Sell

3,513

$22.44

$78.83K

DONNELLY HOWARD W

20 Apr 2022

Director

Exercised, kept

6,022

$15.95

$96.05K

JOHNSON WESLEY

12 Apr 2022

Director

Sell

1,299

$23.26

$30.21K

JOHNSON WESLEY

11 Apr 2022

Director

Sell

6,201

$23.00

$142.62K

Trowbridge Stephen A

12 Jan 2022

EVP and CFO

Buy

1,000

$22.64

$22.64K

Clemmer James C

11 Jan 2022

President and CEO

Buy

10,000

$22.84

$228.40K

Helsel Dave

20 Oct 2021

SVP Global Operations and R&D

Sell

3,494

$27.97

$97.73K

Centea Scott

15 Oct 2021

Sr. VP/GM, Global VIT

Sold after exercise

12,000

$27.92

$335.04K

Campbell Chad Thomas

5 Oct 2021

SVP/GM, Vascular Access

Sold after exercise

10,748

$27.15

$291.81K

JOHNSON WESLEY

28 Jul 2021

Director

Exercised, kept

5,726

$14.64

$83.83K

Meteny Dennis S

28 Jul 2021

Director

Exercised, kept

5,726

$14.64

$83.83K

Trowbridge Stephen A

15 Apr 2021

EVP and CFO

Exercised, kept

13,625

$14.07

$191.70K

Helsel Dave

14 Apr 2021

SVP Global Operations and R&D

Sell

3,500

$23.93

$83.76K

DONNELLY HOWARD W

1 Apr 2021

Director

Exercised, kept

5,726

$14.64

$83.83K

JOHNSON WESLEY

20 Jan 2021

Director

Sell

6,500

$18.53

$120.45K

Trowbridge Stephen A

11 Aug 2020

EVP and CFO

Buy

1,013

$9.38

$9.50K

Clemmer James C

31 Jul 2020

President and CEO

Buy

40,000

$8.26

$330.40K

Clemmer James C

25 Oct 2019

President and CEO

Buy

15,000

$14.19

$212.85K

JOHNSON WESLEY

6 Aug 2019

Director

Exercised, kept

6,650

$10.68

$71.02K

Gould Kevin J

16 Jul 2019

Director

Sold after exercise

13,650

$21.45

$292.79K

GOLD JEFFREY

12 Jul 2019

Director

Exercised, kept

6,650

$10.68

$71.02K

Meteny Dennis S

31 May 2019

Director

Exercised, kept

6,650

$10.68

$71.02K

Greiner Michael

7 Nov 2018

EVP and CFO

Sell

1,939

$21.53

$41.75K

GOLD JEFFREY

6 Jul 2018

Director

Exercised, kept

7,000

$13.53

$94.71K

JOHNSON WESLEY

22 Jun 2018

Director

Exercised, kept

14,000

$13.53

$189.42K

GOLD JEFFREY

21 Jun 2018

Director

Exercised, kept

7,000

$13.53

$94.71K

DONNELLY HOWARD W

21 Jun 2018

Director

Exercised, kept

6,650

$10.68

$71.02K

Meteny Dennis S

21 Jun 2018

Director

Exercised, kept

14,000

$13.53

$189.42K

DONNELLY HOWARD W

21 Nov 2017

Director

Exercised, kept

14,000

$13.53

$189.42K

Richard Stark

15 Nov 2017

SVP, GM - Oncology

Sold after exercise

27,409

$16.29

$446.49K

Gould Kevin J

12 Sep 2017

Director

Exercised, kept

14,000

$13.53

$189.42K

Gould Kevin J

12 Sep 2017

Director

Exercised, kept

25,000

$14.31

$357.75K

GOLD JEFFREY

25 Jul 2017

Director

Exercised, kept

14,000

$15.75

$220.50K

Meteny Dennis S

25 Jul 2017

Director

Exercised, kept

14,000

$15.75

$220.50K

JOHNSON WESLEY

25 Jul 2017

Director

Exercised, kept

14,000

$15.75

$220.50K

REED JAN STERN

24 Jul 2017

Director

Buy

316

$16.00

$5.06K

Clemmer James C

21 Jul 2017

President and CEO

Buy

5,000

$15.79

$78.95K

DONNELLY HOWARD W

21 Jul 2017

Director

Buy

5,000

$15.72

$78.60K

Clemmer James C

20 Jul 2017

President and CEO

Buy

20,000

$15.64

$312.80K

DONNELLY HOWARD W

19 Jun 2017

Director

Exercised, kept

14,000

$15.75

$220.50K

Avista Capital Partners GP, LLC

12 Apr 2017

10% owner

Sell indirect

384,184

$16.00

$6.15M

Avista Capital Partners GP, LLC

12 Apr 2017

10% owner

Sell indirect

508,869

$16.00

$8.14M

Avista Capital Partners GP, LLC

12 Apr 2017

10% owner

Sell indirect

1,456,947

$16.00

$23.31M

Burgstahler David F

12 Apr 2017

Director

Sell indirect

384,184

$16.00

$6.15M

Burgstahler David F

12 Apr 2017

Director

Sell indirect

508,869

$16.00

$8.14M

Burgstahler David F

12 Apr 2017

Director

Sell indirect

1,456,947

$16.00

$23.31M

LaPorte Steve

13 Jan 2017

Director

Exercised, kept

14,000

$15.75

$220.50K

Avista Capital Partners GP, LLC

18 Nov 2016

10% owner

Sell indirect

541,349

$15.68

$8.49M

Avista Capital Partners GP, LLC

18 Nov 2016

10% owner

Sell indirect

1,549,945

$15.68

$24.30M

Burgstahler David F

18 Nov 2016

Director

Sell indirect

541,349

$15.68

$8.49M

Burgstahler David F

18 Nov 2016

Director

Sell indirect

1,549,945

$15.68

$24.30M

By person

Individual transactions

What was left out